New stock announcement | Pharmalink (02268) received a subscription to public offering at 49.96 times the number of shares offered, with each share priced at HKD 20.6.

Yao Ming He Lian (02268) announced the results of the placement, with the offering price set at HKD 20.60 per share. The company will receive a net amount of approximately HKD 3.483 billion from the global offering. Trading of the shares is expected to begin on November 17, 2023 (Friday) at 9:00 am, with a minimum trading size of 500 shares. The preliminary offering of shares in Hong Kong received a significantly oversubscribed response. There were a total of 30,700 valid applications, with a total subscription of 892 million shares, which is approximately 49.96 times the initial offering size of 17.845 million shares in Hong Kong. Due to the oversubscription of the Hong Kong offering, a reallocation process has been conducted. A total of 35.689 million shares from the international offering have been reallocated to the Hong Kong offering. The final number of shares offered in Hong Kong is 53.534 million, accounting for approximately 30% of the initial offering size globally. The number of successful applicants in Hong Kong is 14,800, including 8,362 applicants who will receive one trading unit (500 shares). The preliminary offering of shares in the international offering also received a significantly oversubscribed response. A total of 3.148 billion shares were subscribed, which is approximately 19.60 times the initial offering size of 161 million shares in the international offering (including 8.922 million shares reserved for preferential offering). After the reallocation to the Hong Kong offering, the final number of shares offered in the international offering is 125 million shares (including 8.922 million shares reserved for preferential offering), accounting for approximately 70% of the initial offering size globally (before exercise of the oversubscription option). A total of 19.1585 million shares have been allocated in excess in the international offering, with a total of 170 underwriters. Among them, 67 underwriters (about 39.4% of the total number of underwriters in the international offering) have been allocated five trading units or less of the shares. These underwriters have been allocated a total of 68,500 shares, accounting for approximately 0.043% of the initial offering size in the international offering and approximately 0.038% of the total offering size globally (assuming the oversubscription option is not exercised). Based on the offering price of HKD 20.60 per share, and according to the cornerstone investment agreement, cornerstone investors will be allocated a total of 114 million shares, representing approximately (i) 63.83% of the shares offered in the global offering and (ii) 9.67% of the total issued share capital of the company after the completion of the global offering (assuming the oversubscription option is not exercised).